Drug-induced liver injury - Types and phenotypes

Research output: Contribution to journalReview articlepeer-review

Abstract

Drug-induced liver injury is an uncommon but challenging clinical problem with respect to both diagnosis and management.1-3 Its incidence is estimated to be 14 to 19 cases per 100,000 persons, with jaundice accompanying 30% of cases.4,5 Drug-induced liver injury is responsible for 3 to 5% of hospital admissions for jaundice6 and is the most frequent cause of acute liver failure in most Western countries, accounting for more than half of cases.7,8 Advances have been made in our understanding of viral, autoimmune, and genetic liver diseases, as well as approaches to their prevention and treatment, but progress on these fronts has been modest in the case of drug-induced liver injury.

Original languageEnglish
Pages (from-to)264-273
Number of pages10
JournalNew England Journal of Medicine
Volume381
Issue number3
DOIs
Publication statusPublished - 18 Jul 2019

Bibliographical note

Publisher Copyright: © 2019 Massachusetts Medical Society.

Fingerprint

Dive into the research topics of 'Drug-induced liver injury - Types and phenotypes'. Together they form a unique fingerprint.

Cite this